What is MolecuLight?
MolecuLight specializes in the development of sophisticated wound care devices that utilize proprietary fluorescence imaging technology. By providing clinicians with real-time visualization of bacterial presence, the company enables more accurate wound assessments and data-driven treatment plans. Their product suite, which integrates seamlessly with electronic health records, is designed to enhance clinical decision-making, reduce the time required for wound healing, and improve overall patient care standards. As a leader in the diagnostic medical device space, MolecuLight is uniquely positioned to address the growing global demand for precision medicine and efficient wound management workflows.
How much funding has MolecuLight raised?
MolecuLight has raised a total of $23.2M across 3 funding rounds:
Angel/Seed
$4M
Other Financing Round
$7.5M
Series C
$11.7M
Angel/Seed (2014): $4M with participation from iGan Partners
Other Financing Round (2019): $7.5M led by Oxford Finance
Series C (2024): $11.7M supported by Azahar Global Capital, Export Development Canada, and Prosegur
Key Investors in MolecuLight
iGan Partners
iGan Partners is a prominent healthcare-focused venture capital firm that partners with founders to commercialize and scale innovative medical solutions across North America.
Oxford Finance
Oxford Finance is a specialty finance firm providing flexible capital solutions tailored to the unique needs of healthcare and life sciences companies globally.
Export Development Canada
Export Development Canada is a financial institution providing risk management and secure financing services to support the growth of Canadian enterprises.
What's next for MolecuLight?
With the successful closure of this major strategic investment, MolecuLight is well-positioned to accelerate its commercial expansion and deepen its market penetration. The company is expected to focus on scaling its sales infrastructure and enhancing its digital health integration capabilities to meet the needs of large-scale healthcare providers. By maintaining its commitment to innovation in fluorescence imaging, MolecuLight aims to solidify its role as an essential partner in the global wound care ecosystem, driving long-term value for both clinical stakeholders and investors alike.
See full MolecuLight company page
